Скачать или смотреть Biotech Financing Outlook 2023

The Biotech market has seen an unprecedented influx of funding and IPOs have also reached record levels in 2020 and 2021. But in 2022, things started to change. Funding dried up and the IPOs have become rare.

We recently had the chance to sit down with Richard Murphey from Bay Bridge Bio to have a closer look at the market and what the changing sentiment means for Biotech companies and their funding strategy this year.

In this 15-minute conversation, Richard discusses:
• 2022 market recap
• What to look for in 2023
• Fundraising, IPO and M&A market in 2023
• How to prepare for volatile markets

About Sage:
Sage develops business cloud software products for small and mid-sized businesses. Our Sage Business Cloud delivers cloud-based business management software and services across accounting, human resources, payroll, fixed assets, and enterprise resource management.

Visit Sage: http://1sa.ge/YYJj50Cyi0E
Read our blog: http://1sa.ge/bUtZ50CyhZJ
Like us on Facebook: http://1sa.ge/aYtq50Cyi22
Follow us on Twitter: http://1sa.ge/I86350Cyi3B
Find us on LinkedIn: http://1sa.ge/m5DP50Cyi6x

#Sage